Cargando…
Novel Immunotherapeutics for the Treatment of Glioblastoma: The Last Decade of Research
Despite surgical resection and adjuvant chemoradiation, survival for glioblastoma remains poor. Because of the dismal prognosis, attention has shifted to alternative adjuvant treatment modalities. Although traditionally limited to systemic malignancies (melanoma, lung and colon cancer), the field of...
Autores principales: | Khansur, Emaad M, Shah, Ashish H, Lacy, Kyle, Kuchakulla, Manish, Komotar, Ricardo J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910011/ https://www.ncbi.nlm.nih.gov/pubmed/29692957 http://dx.doi.org/10.7759/cureus.2130 |
Ejemplares similares
-
Revisiting the Relationship Between Ethnicity and Outcome in Glioblastoma Patients
por: Shah, Ashish H, et al.
Publicado: (2017) -
Postoperative Seizure Rate After Transcortical Resection of Subcortical Brain Tumors and Colloid Cysts: A Single Surgeon’s Experience
por: Eichberg, Daniel G, et al.
Publicado: (2018) -
The Use of Dehydrated Amniotic Membrane Allograft for the Augmentation of Dural Repair in Craniotomies
por: Eichberg, Daniel G, et al.
Publicado: (2018) -
A Novel Blood-Brain Barrier-Permeable Chemotherapeutic Agent for the Treatment of Glioblastoma
por: Ozawa, Tomoko, et al.
Publicado: (2021) -
Remote Cerebellar Hemorrhage Associated With Intra-Operative Cerebrospinal Fluid Leak: A Report of Two Rare Case Presentations and Review of the Literature
por: Di, Long, et al.
Publicado: (2020)